Deepverge (formerly Integumen) is a vertically integrated business, collaborating technology platforms with partners in artificial intelligence, clinical research, water technologies, medical device and life science.

These collaborators are building their own technology on top of the Labskin AI backbone. Labskin allows skin-care, health-care, pharmaceutical manufacturers and cosmetic companies to test their products on human-like skin in a real-world environment with full access to multiple state-of-the-art partner technologies.

“Deepverge is expanding, with organic revenue growth alone, despite COVID, guided at £4m for 2020, including an increase in revenues by 300% in H2 2020, up from £1m in H1 2020. Following the recent acquisition of Modern Water plc, we will now have sales offices and laboratories for Labskin and Rinocloud AI services in the US, Ireland, UK, China and Japan. This global expansion provides access to a growing list of household name clients, that includes Unilever, L’Oréal, Estee Lauder, Walgreens Boots Alliance, Amway and L’Occitane, cross-selling products and services from each division and serving the environment, cosmetics and pharma sectors worldwide.

https://www.share-talk.com/gerard-j-brandon-ceo-of-deepverge-plc-dvrg-l-interview/